CORRECTION
Jankowski J, Perry HM, Medina CB, Huang L, Yao J, Bajwa A, Lorenz UM, Rosin DL, Ravichandran KS, Isakson BE, Okusa MD: Epithelial and endothelial pannexin1 channels mediate AKI. J Am Soc Nephrol 29: 1887–1899, 2018.
The dose of carbenoxolone administered to mice was written incorrectly in the following three instances:
Carbenoxolone (CBX, C4790; Sigma-Aldrich) was prepared in a vehicle of normal saline, and it was administered (245 mg/kg intraperitoneally) 1 hour before IRI (Supplemental Figure 2A).
Plasma creatinine was elevated in vehicle-treated C57BL/6 mice after ischemia-reperfusion, but it was attenuated by a single injection of CBX (245 mg/kg intraperitoneally) (Figure 1A) given 1 hour before IRI (Supplemental Figure 2A).
Mice were treated with vehicle (saline; n=7) or carbenoxolone (CBX; 245 mg/kg intraperitoneally; n=4) 1 hour before IRI.
The correct dose and the one that was administered, is 0.245 mg/kg. This correction has no effect on the interpretation of data or conclusions of the article. We apologize for the mistake.
Footnotes
Published online ahead of print. Publication date available at www.jasn.org.